<DOC>
	<DOCNO>NCT01400607</DOCNO>
	<brief_summary>ISTO Technologies , Inc. propose clinical study 225 subject , establish safety efficacy Neocartilage Implant treatment ICRS Grade 3 4 articular cartilage lesion knee compare microfracture treatment .</brief_summary>
	<brief_title>Neocartilage Implant Treat Cartilage Lesions Knee</brief_title>
	<detailed_description>In United States alone , 500,000 cartilage lesion per year require treatment reduce pain , restore joint mobility , prevent damage cause progression osteoarthritis . The lack effective cartilage repair approach product restoration defective articular cartilage native , hyaline morphology continue exacerbate incidence osteoarthritis initial defect enlarge degrade 10 20 year period . The repair cartilage , especially knee , remain formidable clinical challenge . Regenerative medicine approach cartilage repair begin explore possible option clear trend toward biological solution repair regeneration damage diseased articular cartilage . The study design compare well Neocartilage Implant work microfracture therapy , widely use accepted cartilage repair therapy . Data collect include Pain Function Daily Living score , symptom , Function Sports Recreation , Knee Related Quality Life . Additionally , MRI X-rays collect evaluate cartilage repair progress . These assessment use five year post-operative follow-up .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Cartilage Diseases</mesh_term>
	<criteria>Generally , follow inclusion criterion must meet , however , complete list . Male Female age 18 60 ( 1 ) ( 2 ) articular cartilage lesion distal femur range 5 cm2 Ipsilateral knee compartment intact meniscus ( meniscectomized remnant &gt; 5mm wide rim ) stable ligament affect knee 3 month initiation conservative nonsurgical management ( e.g.hyaluronic acid injection , activity modification ) previous minimal surgical intervention ( e.g. , arthroscopic lavage , debridement ) 12 month marrow stimulation condition Generally , potential participant meet follow criterion , eligible study . Additionally , criterion evaluate confirm eligibility list complete list criterion . Osteoarthritis Rheumatoid arthritis History septic reactive arthritis Gout history gout pseudogout affect knee Osteochondritis dissecans osteochondral lesion knee bone loss &gt; 6mm deep Bipolar articular cartilage involvement ( kiss lesion ) ipsilateral compartment ( i.e. , &gt; ICRS Grade 2 oppose articular surface ) Associated damage underlie subchondral bone require osteochondral graft Is pregnant breastfeeding Has BMI &gt; 35 ( kg/m2 ) Has prior total meniscectomy either knee Has receive , within past three month , intraarticular hyaluronic acid therapy , steroid therapy Has two clinically relevant chondral lesion ( ) index knee</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>cartilage</keyword>
	<keyword>knee surgery</keyword>
	<keyword>cartilage injury</keyword>
	<keyword>knee pain</keyword>
	<keyword>cartilage repair</keyword>
	<keyword>cartilage damage</keyword>
	<keyword>cartilage lesion</keyword>
	<keyword>cartilage defect</keyword>
	<keyword>articular cartilage lesion</keyword>
	<keyword>articular cartilage defect</keyword>
	<keyword>juvenile</keyword>
	<keyword>cell</keyword>
	<keyword>ISTO Technologies</keyword>
	<keyword>Neocartilage</keyword>
	<keyword>RevaFlex</keyword>
</DOC>